Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;24(4):1265-1279.
doi: 10.1007/s11030-019-09990-z. Epub 2019 Sep 10.

Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents

Affiliations

Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents

Ashutosh Prasad Tiwari et al. Mol Divers. 2020 Nov.

Abstract

Diphenyl ether derivatives inhibit mycobacterial cell wall synthesis by inhibiting an enzyme, enoyl-acyl carrier protein reductase (InhA), which catalyses the last step in the fatty acid synthesis cycle of genus Mycobacterium. To select and validate a protein crystal structure of enoyl-acyl carrier protein reductase of Mycobacterium tuberculosis for designing inhibitors using molecular modelling, a cross-docking and correlation study was performed. A series of novel 1-(3-(3-hydroxy-4-phenoxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl) ethan-1-ones were synthesized from this model and screened for their antitubercular activity against M. tuberculosis H37Rv. Compound PYN-8 showed good antitubercular activity on M. tuberculosis H37Rv (MIC = 4-7 µM) and Mycobacterium bovis (% inhibition at 10 µM = 95.91%). Cytotoxicity of all the synthesized derivatives was assessed using various cell lines, and they were found to be safe. Structure of PYN-8 was also confirmed by single-crystal X-ray diffraction. The molecular modelling studies also corroborated the biological activity of the compounds. Further, in silico findings revealed that all these tested compounds exhibited good ADME properties and drug likeness and thus may be considered as potential candidates for further drug development.

Keywords: Antitubercular; Correlation study; Diphenylether; InhA; Molecular docking; TB.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors confirm that this article content has no conflict of interest.

Figures

Figure 1.
Figure 1.
Design strategy and active site of InhA showing diphenyl ether derivative substituted at 5th chlorine position protruding into the isonicotinoyl binding pocket containing InhA complexes of isoniazid (red colour) and ethionamide (yellow colour)
Figure 2.
Figure 2.
Binding free energy vs pIC50 correlation graph with correlation value R2
Figure 3.
Figure 3.
Induced fit docked pose of PYN-8 on 3FNE
Figure 4.
Figure 4.
Induced fit docked pose of Triclosan on 3FNE
Figure 5.
Figure 5.
Water map of 3FNE protein showing PYN-8 displacing water site number 68
Figure 6.
Figure 6.
ORTEP diagram of PYN-8. Displacement ellipsoids are drawn at the 30% probability level.
Figure 8.
Figure 8.
All 11 crystal structures aligned over 2X23 crystal structure
Figure 9.
Figure 9.
All the extracted ligands aligned using flexible ligand alignment
Scheme 1.
Scheme 1.. Synthesis of pyrazoline derivatives of diphenyl ethers (PYN series)
1) Phenyl boronic acid 2) 3-hydroxy-4-phenoxy 3) 1-(3-methoxy-4-phenoxyphenyl)ethan-1-one 4) 1-(3-hydroxy-4-phenoxyphenyl)ethan-1-one 5) (E)-1-(3-hydroxy-4-phenoxyphenyl)-3-phenylprop-2-en-1-one 6) 1-(3-(3-hydroxy-4-phenoxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one acetophenone a) Copper acetate monohydrate, Pyridine, anhydrous dichloromethane, 4Å Molecular Sieves b) BBr3, anhydrous dichloromethane, −78°C c) Substituted benzaldehydes, LiOH.H2O, Ethanol d) Hydrazine hydrate, Glacial acetic acid

Similar articles

Cited by

References

    1. WHO | Tuberculosis (TB). WHO [Internet]. World Health Organization; 2018. [cited 2019 Mar 1]; Available from: https://www.who.int/gho/tb/en/
    1. World Health Organization. BCG vaccine: WHO position paper, February 2018 – Recommendations. Vaccine. 2018. - PubMed
    1. WHO. Guidelines for treatment of drug-susceptible tuberculosis and patient care. World Health Organization. 2017.
    1. Rožman K, Sosič I, Fernandez R, Young RJ, Mendoza A, Gobec S, et al. A new ‘golden age’ for the antitubercular target InhA. Drug Discovery Today. 2017. - PubMed
    1. Forrellad MA, Klepp LI, Gioffré A, Sabio y García J, Morbidoni HR, Santangelo M de la P, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013; - PMC - PubMed

MeSH terms